TickerLeague

Capital Expenditures for Baxter International (BAX)

According to Baxter International's latest reported financial statements, the company's current capital expenditures (TTM) is $522.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Currently viewingCapital Expenditures

Latest period

$522.00M

YoY change

+13.5%

5Y CAGR

-5.9%

Peak year (2012)

$1.16B

Cumulative capital expenditures

$24.26B

CapEx history chart for Baxter International (BAX) from 1989 to 2025

CapEx history table for Baxter International (BAX) from 1989 to 2025

Fiscal yearPeriod endedReportedCapital ExpendituresYoY
2025$522.00M+13.5%
2024$460.00M+5.5%
2023$436.00M-31.3%
2022$635.00M-8.1%
2021$691.00M-2.5%
2020$709.00M+1.9%
2019$696.00M+5.6%
2018$659.00M+7.0%
2017$616.00M-14.3%
2016$719.00M-21.1%
2015$911.00M-1.5%
2014$925.00M+31.0%
2013$706.00M-39.2%
2012$1.16B+20.9%
2011$960.00M-0.3%
2010$963.00M-5.0%
2009$1.01B+6.3%
2008$954.00M+37.9%
2007$692.00M+31.6%
2006$526.00M+18.5%
2005$444.00M-20.4%
2004$558.00M-29.3%
2003$789.00M-7.0%
2002$848.00M+11.7%
2001$759.00M+10.8%
2000$685.00M+8.6%
1999$631.00M+13.5%
1998$556.00M+22.5%
1997$454.00M+14.1%
1996$398.00M-0.3%
1995$399.00M-20.5%
1994$502.00M-2.7%
1993$516.00M-3.9%
1992$537.00M+0.9%
1991$532.00M+45.0%
1990$367.00M+10.9%
1989$331.00M

CapEx values are taken from Baxter International's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Baxter International (BAX) reported capital expenditures of $522.00M – grew 13.5% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Baxter International capital expenditures compounded at -5.9% per year, sustaining 2 straight years of year-over-year growth.

Baxter International capital expenditures peaked at $1.16B in 2012; the latest annual figure is $522.00M in 2025 (55.0% below peak).

The highest annual capital expenditures of $1.16B was reported in 2012. The lowest in the available history was $331.00M in 1989.

Within Healthcare, Baxter International (BAX) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.

Baxter International Capital Expenditures by Year

Baxter International Capital Expenditures 2025: $522.00M

Baxter International capital expenditures in 2025 was $522.00M, grew 13.5% from 2024.

Baxter International Capital Expenditures 2024: $460.00M

Baxter International capital expenditures in 2024 was $460.00M, grew 5.5% from 2023.

Baxter International Capital Expenditures 2023: $436.00M

Baxter International capital expenditures in 2023 was $436.00M, plunged 31.3% below 2022.

Baxter International Capital Expenditures 2022: $635.00M

Baxter International capital expenditures in 2022 was $635.00M, declined 8.1% below 2021.

Baxter International Capital Expenditures 2021: $691.00M

Baxter International capital expenditures in 2021 was $691.00M.

See more financial history for Baxter International (BAX).

Sector peers — CapEx

Companies in the same sector as Baxter International, ranked by their latest capital expenditures.

CompanyCapital ExpendituresSector
Novo Nordisk A/S (NVO)$90.11BHealthcare
Eli Lilly and Company (LLY)$7.84BHealthcare
Johnson & Johnson (JNJ)$4.83BHealthcare
Merck & Co., Inc. (MRK)$4.11BHealthcare
UnitedHealth Group Incorporated (UNH)$3.62BHealthcare
AstraZeneca PLC (AZN)$2.81BHealthcare
Amgen Inc. (AMGN)$1.86BHealthcare
AbbVie Inc. (ABBV)$1.21BHealthcare

Frequently asked questions

What is Baxter International's capital expenditures?

Latest reported capital expenditures for Baxter International (BAX) is $522.00M (period ending December 31, 2025).

How has Baxter International capital expenditures changed year-over-year?

Baxter International (BAX) capital expenditures changed +13.5% year-over-year on the latest annual filing.

What is the long-term growth rate of Baxter International capital expenditures?

Baxter International (BAX) capital expenditures compound annual growth rate is -5.9% over the most recent 5 years available.

When did Baxter International capital expenditures hit its highest annual value?

Baxter International capital expenditures reached its highest annual value of $1.16B in 2012.

What was Baxter International capital expenditures in 2024?

Baxter International (BAX) capital expenditures in 2024 was $460.00M.

What was Baxter International capital expenditures in 2025?

Baxter International (BAX) capital expenditures in 2025 was $522.00M.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.